MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue102,155132,499166,858
Cost of Revenue71,71088,026109,927
Gross Profit30,44544,47356,931
Operating Expenses
Research Development6421,8694,251
Selling General and Administrative36,81250,36184,334
Non Recurring18090118,293
Total Operating Expenses---
Operating Income or Loss-7,189-8,658-49,947
Income from Continuing Operations
Total Other Income/Expenses Net-3,6425,499-1,806
Earnings Before Interest and Taxes-10,831-3,159-51,753
Interest Expense---
Income Before Tax-10,831-3,159-51,753
Income Tax Expense142318105
Minority Interest---
Net Income From Continuing Ops-10,973-3,477-51,858
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-10,973-3,477-51,858
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-10,973-3,477-51,858